Development of PROTACs for targeted degradation of oncogenic TRK fusions
Saurav Kumar, Jiewei Jiang, Mia S. Donald-Paladino…·Behnam Nabet
This paper develops PROTACs to degrade oncogenic TRK fusions, showing improved efficacy compared to traditional inhibitors.